Cargando…

Antimicrobial utilization and antimicrobial resistance in patients with haematological malignancies in Japan: a multi-centre cross-sectional study

BACKGROUND: Infection is a major complication for patients with haematological malignancies. It is important to better understand the use of antimicrobial agents and antibiotic resistance for appropriate treatment and prevention of drug resistance. However, very few multi-centre analyses have focuse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mimura, Wataru, Fukuda, Haruhisa, Akazawa, Manabu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027235/ https://www.ncbi.nlm.nih.gov/pubmed/32066448 http://dx.doi.org/10.1186/s12941-020-00348-0

Ejemplares similares

Cost and healthcare utilization of methicillin-resistant Staphylococcus aureus bacteremia estimated from linked antimicrobial resistance surveillance and hospital claims data in Japan
por: Shoji, Tomokazu, et al.
Publicado: (2022)

The Association Between Internet Searches and Moisturizer Prescription in Japan: Retrospective Observational Study
por: Mimura, Wataru, et al.
Publicado: (2019)

Clinical Implication of the Relationship between Antimicrobial Resistance and Infection Control Activities in Japanese Hospitals: A Principal Component Analysis-Based Cluster Analysis
por: Shoji, Tomokazu, et al.
Publicado: (2022)

Measuring hospital-wide activity volume for patient safety and infection control: a multi-centre study in Japan
por: Hayashida, Kenshi, et al.
Publicado: (2007)

Effectiveness of a Third Dose of COVID-19 mRNA Vaccine During the Omicron BA.1- and BA.2-Predominant Periods in Japan: The VENUS Study
por: Mimura, Wataru, et al.
Publicado: (2022)

Effectiveness of messenger RNA vaccines against infection with SARS-CoV-2 during the periods of Delta and Omicron variant predominance in Japan: the Vaccine Effectiveness, Networking, and Universal Safety (VENUS) study
por: Mimura, Wataru, et al.
Publicado: (2022)

Differences in incidence and trends of haematological malignancies in Japan and the United States
por: Chihara, Dai, et al.
Publicado: (2014)

A multi-centre, retrospective case series of oocyte cryopreservation in unmarried women diagnosed with haematological malignancies
por: Kato, K, et al.
Publicado: (2021)

Bivalent Vaccine Effectiveness Among Adults Aged ≥65 Years During the BA.5-Predominant Period in Japan: The VENUS Study
por: Mimura, Wataru, et al.
Publicado: (2023)

Eight-Year Experience of Antimicrobial Stewardship Program and the Trend of Carbapenem Use at a Tertiary Acute-Care Hospital in Japan—The Impact of Postprescription Review and Feedback
por: Akazawa, Tsubasa, et al.
Publicado: (2019)

173. Nationwide Outpatient Oral Antimicrobial Utilization by Children in Japan
por: Kinoshita, Noriko, et al.
Publicado: (2018)

Association between seasonal influenza vaccination and antimicrobial use in Japan from the 2015–16 to 2020–21 seasons: from the VENUS study
por: Tsuzuki, Shinya, et al.
Publicado: (2023)

Third-generation cephalosporin resistant gram-negative bacteraemia in patients with haematological malignancy; an 11-year multi-centre retrospective study
por: de la Court, Jara R., et al.
Publicado: (2022)

Patterns of drug treatment in patients with osteoarthritis and chronic low back pain in Japan: a retrospective database study
por: Akazawa, Manabu, et al.
Publicado: (2019)

Trends in antimicrobial-drug resistance in Japan.
por: Arakawa, Y, et al.
Publicado: (2000)

Antimicrobial resource centre
Publicado: (2019)

2879. Utilization of vector autoregressive models for multivariable time-series analysis to evaluate the difference between days of therapy and days of antibiotic spectrum coverage in an inpatient antimicrobial stewardship program
por: Murakami, Shutaro, et al.
Publicado: (2023)

A Reference Laboratory Surveillance on Fungal Isolates from Patients with Haematological Malignancy in Japan
por: Hino, Yutaro, et al.
Publicado: (2021)

Tertiary trauma care centre & antimicrobial resistance
por: Oncül, Oral
Publicado: (2011)

Nationwide cross-sectional study of antimicrobial stewardship and antifungal stewardship programs in inpatient settings in Japan
por: Moriyama , Yuki, et al.
Publicado: (2021)

Survival of critically ill patients with haematological malignancies compared with patients without haematological malignancy
por: Pugh, R, et al.
Publicado: (2013)

593. Additional medical expenditures attributable to pneumococcal disease in Japan
por: Fukuda, Haruhisa
Publicado: (2020)

Decline in Antimicrobial Consumption and Stagnation in Reducing Disease Burden due to Antimicrobial Resistance in Japan
por: Tsuzuki, Shinya, et al.
Publicado: (2023)

PSYCHOLOGICAL ASPECTS OF HAEMATOLOGICAL MALIGNANCIES
por: Kulhara, P., et al.
Publicado: (1990)

Tuberculosis in Patients with Haematological Malignancies
por: Anibarro, Luis, et al.
Publicado: (2014)

Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network
por: Smith, A, et al.
Publicado: (2011)

Prevalence of anxiety and depression in people with different types of cancer or haematologic malignancies: a cross-sectional study
por: Zeilinger, E. L., et al.
Publicado: (2022)

Associations of heart failure to prevalence of haematologic- and solid malignancies in southern Sweden: A cross-sectional study
por: Scholten, Mia, et al.
Publicado: (2023)

Multiregional Population-Based Cohort Study for Evaluation of the Association Between Herpes Zoster and mRNA Vaccinations for Severe Acute Respiratory Syndrome Coronavirus-2: The VENUS Study
por: Ishiguro, Chieko, et al.
Publicado: (2023)

Contribution of antimicrobial stewardship programs to reduction of antimicrobial therapy costs in community hospital with 429 Beds --before-after comparative two-year trial in Japan
por: Fukuda, Tetsuya, et al.
Publicado: (2014)

Caribbean multi-centre study of Klebsiella pneumoniae: whole-genome sequencing, antimicrobial resistance and virulence factors
por: Heinz, Eva, et al.
Publicado: (2019)

Patients with systemic lupus erythematosus and haematological malignancy at a tertiary care centre: timing, histopathology and therapy
por: Knight, Jason S, et al.
Publicado: (2014)

Clinical profile and outcome of COVID-19 in haematological malignancies: experience from tertiary care centre in India
por: Gupta, Anshul, et al.
Publicado: (2021)

Public knowledge and perception about antimicrobials and antimicrobial resistance in Japan: A national questionnaire survey in 2017
por: Kamata, Kazuhiro, et al.
Publicado: (2018)

Nationwide temporal trend analysis of reperfusion therapy utilization and mortality in acute ischemic stroke patients in Japan
por: Maeda, Megumi, et al.
Publicado: (2021)

Expression of testicular genes in haematological malignancies
por: Lim, S H, et al.
Publicado: (1999)

Clinical use of rituximab in haematological malignancies
por: Avivi, I, et al.
Publicado: (2003)

The Role of miRNA in Haematological Malignancy
por: Gounaris-Shannon, Stephanie, et al.
Publicado: (2013)

Cancer stem cells in haematological malignancies
por: Zagozdzon, Radoslaw, et al.
Publicado: (2015)

Breast imaging findings in haematological malignancies
por: Glazebrook, K. N., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_uf6vd3kv6pl1pd1ufe5rcvihmd